HomeEDSA • NASDAQ
add
Edesa Biotech Inc
Previous close
$1.36
Day range
$1.40 - $1.67
Year range
$0.72 - $2.95
Market cap
13.13M USD
Avg Volume
3.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.34M | 23.32% |
Net income | -2.25M | -38.98% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.32M | -24.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.05M | 670.82% |
Total assets | 14.71M | 253.26% |
Total liabilities | 756.16K | -60.21% |
Total equity | 13.95M | — |
Shares outstanding | 8.35M | — |
Price to book | 2.43 | — |
Return on assets | -41.45% | — |
Return on capital | -44.33% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.25M | -38.98% |
Cash from operations | -2.09M | -37.58% |
Cash from investing | — | — |
Cash from financing | 3.36M | 61.98% |
Net change in cash | 1.26M | 139.38% |
Free cash flow | -1.31M | -54.44% |
About
Founded
2007
Headquarters
Website
Employees
17
